The E2F family and the role of E2F1 in apoptosis

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 12, 2009, Pages 2389-2397

  Wu, Zhenlong ^a   Zheng, Shunsheng ^a   Yu, Qiang ^a  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Cancer cell; E2F; E2F1; Therapeutic target

Indexed keywords

BETA LAPACHONE; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGASE INHIBITOR; NUTLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CARCINOGENESIS; CHEMOSENSITIZATION; DNA DAMAGE; DRUG MECHANISM; DRUG SCREENING; ENZYME REGULATION; GENE ACTIVATION; GENE ACTIVITY; GENE REPRESSION; GENE TARGETING; HUMAN; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION INITIATION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; E2F1 TRANSCRIPTION FACTOR; GENE THERAPY; HUMANS; NEOPLASMS; SALIVARY PROLINE-RICH PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70350270053     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.06.004     Document Type: Review

References (94)

1. Adams P.D., Sellers W.R., Sharma S.K., Wu A.D., Nalin C.M., and Kaelin Jr. W.G. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol 16 (1996) 6623-6633
2. Aguda B.D., Kim Y., Piper-Hunter M.G., Friedman A., and Marsh C.B. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 105 (2008) 19678-19683
3. Almasan A., Yin Y., Kelly R.E., Lee E.Y., Bradley A., Li W., et al. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 92 (1995) 5436-5440
4. Ambrosini G., Sambol E.B., Carvajal D., Vassilev L.T., Singer S., and Schwartz G.K. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1. Oncogene 26 (2007) 3473-3481
5. Ayyanathan K., Lechner M.S., Bell P., Maul G.G., Schultz D.C., Yamada Y., et al. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev 17 (2003) 1855-1869
6. Baehrecke E.H. Autophagy: dual roles in life and death?. Nat Rev Mol Cell Biol 6 (2005) 505-510
7. Bates S., Phillips A.C., Clark P.A., Stott F., Peters G., Ludwig R.L., et al. p14ARF links the tumour suppressors RB and p53. Nature 395 (1998) 124-125
8. Berkovich E., and Ginsberg D. ATM is a target for positive regulation by E2F-1. Oncogene 22 (2003) 161-167
9. Bracken A.P., Ciro M., Cocito A., and Helin K. E2F target genes: unraveling the biology. Trends Biochem Sci 29 (2004) 409-417
10. Bramis J., Zacharatos P., Papaconstantinou I., Kotsinas A., Sigala F., Korkolis D.P., et al. E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res 24 (2004) 3041-3047
11. Cam H., and Dynlacht B.D. Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 3 (2003) 311-316
12. Chaussepied M., and Ginsberg D. Transcriptional regulation of AKT activation by E2F. Mol Cell 16 (2004) 831-837
13. Chen Y.N., Sharma S.K., Ramsey T.M., Jiang L., Martin M.S., Baker K., et al. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc Natl Acad Sci USA 96 (1999) 4325-4329
14. Crosby M.E., Jacobberger J., Gupta D., Macklis R.M., and Almasan A. E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma. Oncogene 26 (2007) 1897-1909
15. Croxton R., Ma Y., Song L., Haura E.B., and Cress W.D. Direct repression of the Mcl-1 promoter by E2F1. Oncogene 21 (2002) 1359-1369
16. DeGregori J., and Johnson D.G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6 (2006) 739-748
17. DeGregori J., Kowalik T., and Nevins J.R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 15 (1995) 4215-4224
18. DeGregori J., Leone G., Miron A., Jakoi L., and Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94 (1997) 7245-7250
19. Dimova D.K., and Dyson N.J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24 (2005) 2810-2826
20. Dong Y.B., Yang H.L., and McMasters K.M. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin. Cancer Gene Ther 10 (2003) 168-178
21. DuPree E.L., Mazumder S., and Almasan A. Genotoxic stress induces expression of E2F4, leading to its association with p130 in prostate carcinoma cells. Cancer Res 64 (2004) 4390-4393
22. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 12 (1998) 2245-2262
23. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin Jr. W.G., Livingston D.M., et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85 (1996) 549-561
24. Finzer P., Krueger A., Stohr M., Brenner D., Soto U., Kuntzen C., et al. HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway. Oncogene 23 (2004) 4807-4817
25. Firestein R., Bass A.J., Kim S.Y., Dunn I.F., Silver S.J., Guney I., et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455 (2008) 547-551
26. Frolov M.V., and Dyson N.J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 117 (2004) 2173-2181
27. Fueyo J., Gomez-Manzano C., Yung W.K., Liu T.J., Alemany R., McDonnell T.J., et al. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat Med 4 (1998) 685-690
28. Hallstrom T.C., Mori S., and Nevins J.R. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13 (2008) 11-22
29. Hallstrom T.C., and Nevins J.R. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc Natl Acad Sci USA 100 (2003) 10848-10853
30. Hallstrom T.C., and Nevins J.R. Jab1 is a specificity factor for E2F1-induced apoptosis. Genes Dev 20 (2006) 613-623
31. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8 (1998) 28-35
32. Hennessy B.T., Smith D.L., Ram P.T., Lu Y., and Mills G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4 (2005) 988-1004
33. Hershko T., Chaussepied M., Oren M., and Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ 12 (2005) 377-383
34. Ianari A., Natale T., Calo E., Ferretti E., Alesse E., Screpanti I., et al. Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell 15 (2009) 184-194
35. Kasahara M., Takahashi Y., Nagata T., Asai S., Eguchi T., Ishii Y., et al. Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer. Clin Cancer Res 6 (2000) 2707-2711
36. Kimura H., Nakamura T., Ogawa T., Tanaka S., and Shiota K. Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways. Nucleic Acids Res 31 (2003) 3101-3113
37. Kitagawa M., Aonuma M., Lee S.H., Fukutake S., and McCormick F. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines. Oncogene 27 (2008) 5303-5314
38. Kovesdi I., Reichel R., and Nevins J.R. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45 (1986) 219-228
39. Kowalik T.F., DeGregori J., Leone G., Jakoi L., and Nevins J.R. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ 9 (1998) 113-118
40. Krek W., Ewen M.E., Shirodkar S., Arany Z., Kaelin Jr. W.G., and Livingston D.M. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78 (1994) 161-172
41. Krek W., Xu G., and Livingston D.M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83 (1995) 1149-1158
42. Lazzerini Denchi E., and Helin K. E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep 6 (2005) 661-668
43. Li J., Ran C., Li E., Gordon F., Comstock G., Siddiqui H., et al. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 14 (2008) 62-75
44. Li Y., Sun X., LaMont J.T., Pardee A.B., and Li C.J. Selective killing of cancer cells by beta-lapachone: direct checkpoint activation as a strategy against cancer. Proc Natl Acad Sci USA 100 (2003) 2674-2678
45. Lin W.C., Lin F.T., and Nevins J.R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15 (2001) 1833-1844
46. Liu K., Luo Y., Lin F.T., and Lin W.C. TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival. Genes Dev 18 (2004) 673-686
47. Liu K., Paik J.C., Wang B., Lin F.T., and Lin W.C. Regulation of TopBP1 oligomerization by Akt/PKB for cell survival. EMBO J 25 (2006) 4795-4807
48. Lukas J., Petersen B.O., Holm K., Bartek J., and Helin K. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol 16 (1996) 1047-1057
49. Maser R.S., Mirzoeva O.K., Wells J., Olivares H., Williams B.R., Zinkel R.A., et al. Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol 21 (2001) 6006-6016
50. Mathew R., Karantza-Wadsworth V., and White E. Role of autophagy in cancer. Nat Rev Cancer 7 (2007) 961-967
51. Mordes D.A., Glick G.G., Zhao R., and Cortez D. TopBP1 activates ATR through ATRIP and a PIKK regulatory domain. Genes Dev 22 (2008) 1478-1489
52. Moroni M.C., Hickman E.S., Lazzerini Denchi E., Caprara G., Colli E., Cecconi F., et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3 (2001) 552-558
53. Morris E.J., Ji J.Y., Yang F., Di Stefano L., Herr A., Moon N.S., et al. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 455 (2008) 552-556
54. Morris E.J., Michaud W.A., Ji J.Y., Moon N.S., Rocco J.W., and Dyson N.J. Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS Genet 2 (2006) e196
55. Nahle Z., Polakoff J., Davuluri R.V., McCurrach M.E., Jacobson M.D., Narita M., et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4 (2002) 859-864
56. Page B.D., Guedes S., Waring D., and Priess J.R. The C. elegans E2F- and DP-related proteins are required for embryonic asymmetry and negatively regulate Ras/MAPK signaling. Mol Cell 7 (2001) 451-460
57. Pediconi N., Ianari A., Costanzo A., Belloni L., Gallo R., Cimino L., et al. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol 5 (2003) 552-558
58. Phillips A.C., Ernst M.K., Bates S., Rice N.R., and Vousden K.H. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell 4 (1999) 771-781
59. Polager S., and Ginsberg D. E2F-at the crossroads of life and death. Trends Cell Biol 18 (2008) 528-535
60. Polager S., Ofir M., and Ginsberg D. E2F1 regulates autophagy and the transcription of autophagy genes. Oncogene 27 (2008) 4860-4864
61. Pomerantz J., Schreiber-Agus N., Liegeois N.J., Silverman A., Alland L., Chin L., et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92 (1998) 713-723
62. Powers J.T., Hong S., Mayhew C.N., Rogers P.M., Knudsen E.S., and Johnson D.G. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res 2 (2004) 203-214
63. Putzer B.M. E2F1 death pathways as targets for cancer therapy. J Cell Mol Med 11 (2007) 239-251
64. Qin X.Q., Livingston D.M., Kaelin Jr. W.G., and Adams P.D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91 (1994) 10918-10922
65. Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L., and Wolffe A.P. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25 (2000) 338-342
66. Salon C., Eymin B., Micheau O., Chaperot L., Plumas J., Brambilla C., et al. E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short). Cell Death Differ 13 (2006) 260-272
67. Schultz D.C., Ayyanathan K., Negorev D., Maul G.G., and Rauscher III F.J. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16 (2002) 919-932
68. Schwarz J.K., Bassing C.H., Kovesdi I., Datto M.B., Blazing M., George S., et al. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc Natl Acad Sci USA 92 (1995) 483-487
69. Sherr C.J., and McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2 (2002) 103-112
70. Sherr C.J., and Weber J.D. The ARF/p53 pathway. Curr Opin Genet Dev 10 (2000) 94-99
71. Stanelle J., and Putzer B.M. E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol Med 12 (2006) 177-185
72. Stevaux O., and Dyson N.J. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol 14 (2002) 684-691
73. Stevens C., and La Thangue N.B. E2F and cell cycle control: a double-edged sword. Arch Biochem Biophys 412 (2003) 157-169
74. Stevens C., Smith L., and La Thangue N.B. Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol 5 (2003) 401-409
75. Tan J., Zhuang L., Jiang X., Yang K.K., Karuturi K.M., and Yu Q. Apoptosis signal-regulating kinase 1 is a direct target of E2F1 and contributes to histone deacetylase inhibitor-induced apoptosis through positive feedback regulation of E2F1 apoptotic activity. J Biol Chem 281 (2006) 10508-10515
76. Tanaka H., Matsumura I., Ezoe S., Satoh Y., Sakamaki T., Albanese C., et al. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9 (2002) 1017-1029
77. Trimarchi J.M., Fairchild B., Wen J., and Lees J.A. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc Natl Acad Sci USA 98 (2001) 1519-1524
78. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3 (2002) 11-20
79. Tsai K.Y., Hu Y., Macleod K.F., Crowley D., Yamasaki L., and Jacks T. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 2 (1998) 293-304
80. Urist M., Tanaka T., Poyurovsky M.V., and Prives C. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev 18 (2004) 3041-3054
81. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 (2004) 844-848
82. Vigo E., Muller H., Prosperini E., Hateboer G., Cartwright P., Moroni M.C., et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 19 (1999) 6379-6395
83. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2 (2002) 594-604
84. Wang C., Chen L., Hou X., Li Z., Kabra N., Ma Y., et al. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 8 (2006) 1025-1031
85. Wang C., Ivanov A., Chen L., Fredericks W.J., Seto E., Rauscher III F.J., et al. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J 24 (2005) 3279-3290
86. Wang C., Rauscher III F.J., Cress W.D., and Chen J. Regulation of E2F1 function by the nuclear corepressor KAP1. J Biol Chem 282 (2007) 29902-29909
87. Wu L., Timmers C., Maiti B., Saavedra H.I., Sang L., Chong G.T., et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414 (2001) 457-462
88. Wu X., and Levine A.J. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91 (1994) 3602-3606
89. Xu G., Livingston D.M., and Krek W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci USA 92 (1995) 1357-1361
90. Xu M., Sheppard K.A., Peng C.Y., Yee A.S., and Piwnica-Worms H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 14 (1994) 8420-8431
91. Yamasaki L., Jacks T., Bronson R., Goillot E., Harlow E., and Dyson N.J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85 (1996) 537-548
92. Yang H.L., Dong Y.B., Elliott M.J., Liu T.J., Atienza Jr. C., Stilwell A., et al. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells. Clin Cancer Res 5 (1999) 2242-2250
93. Zalmas L.P., Zhao X., Graham A.L., Fisher R., Reilly C., Coutts A.S., et al. DNA-damage response control of E2F7 and E2F8. EMBO Rep 9 (2008) 252-259
94. Zhao Y., Tan J., Zhuang L., Jiang X., Liu E.T., and Yu Q. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 102 (2005) 16090-16095